THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kelly Standifer to Naloxone

This is a "connection" page, showing publications Kelly Standifer has written about Naloxone.
Connection Strength

0.368
  1. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells. Neurosci Lett. 2001 Feb 23; 299(3):173-6.
    View in: PubMed
    Score: 0.186
  2. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone. Mol Pharmacol. 1991 Mar; 39(3):290-8.
    View in: PubMed
    Score: 0.093
  3. Sigma binding in a human neuroblastoma cell line. Neurochem Res. 1996 Nov; 21(11):1309-14.
    View in: PubMed
    Score: 0.034
  4. Synthesis and characterization of substituted benzoylhydrazones of naloxone. Synapse. 1996 Oct; 24(2):193-201.
    View in: PubMed
    Score: 0.034
  5. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett. 1995 Sep 29; 198(2):99-102.
    View in: PubMed
    Score: 0.008
  6. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J Neurochem. 1995 Jul; 65(1):170-5.
    View in: PubMed
    Score: 0.008
  7. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov; 251(2):477-83.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES